Enamel Matrix Derivative has No Effect on the Chondrogenic Differentiation of Mesenchymal Stem Cells

Background: Treatment of large bone defects due to trauma, tumor resection, or congenital abnormalities is challenging. Bone tissue engineering using mesenchymal stem cells (MSCs) represents a promising treatment option. However, the quantity and quality of engineered bone tissue are not sufficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Groeneveldt, Lisanne C., Knuth, Callie, Witte-Bouma, Janneke, O’Brien, Fergal J., Wolvius, Eppo B., Farrell, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151337/
https://www.ncbi.nlm.nih.gov/pubmed/25229057
http://dx.doi.org/10.3389/fbioe.2014.00029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151337/
https://www.ncbi.nlm.nih.gov/pubmed/25229057
http://dx.doi.org/10.3389/fbioe.2014.00029

Ejemplares similares